Combating Antibiotic Resistance in Africa with Data Science
Official title: Combatting AntiMicrobial Resistance in Africa Using Data Science (CAMRA)
Funded at Redeemer's University · NIH-11515605 · Data updated 2026-11-12
A patient-friendly overview of a program using data and genomics to track and fight antibiotic resistance in Africa, with potential benefits for global health and future treatments.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Redeemer's University NIH-funded |
| Lab location | 1 site (Ede, NIGERIA) |
| Project start | September 15, 2021 |
| Project end | June 30, 2027 |
| Funding year | 2026 |
| Award (this year) | $318,996 |
| NIH project number | 3U54TW012056-05S2 |
| Project ID | NIH-11515605 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients in Africa and globally who suffer from serious bacterial infections, including children, whose samples may be used for genomic analysis or who could benefit from improved antibiotic stewardship.
✕Less likely to help
Patients without access to healthcare settings where data-driven surveillance is implemented may not directly benefit.
What this research studies
This program focuses on strengthening how we monitor antibiotic resistance in Africa by using data science and genomic sequencing. It aims to better understand how resistant bacteria spread between Africa and the United States and to improve how healthcare teams choose effective antibiotics. By collaborating with laboratories in Africa, the project will analyze patient samples like blood and urine to map resistance patterns. The work could lead to smarter antibiotic use and faster detection of dangerous outbreaks that could affect patients worldwide.
Why it matters
Potential benefit: If successful, this work could lead to quicker, more accurate antibiotic choices and better infection control, potentially saving lives.
How similar studies have gone: Similar genomic surveillance efforts have shown that data-driven tracking can reduce the spread of resistant bacteria and guide treatment choices.
Where this research is happening
-
Redeemer's University
Ede, Nigeria Active
Researchers
- Principal investigator: Happi, Christian T. — Redeemer's University
- Study coordinator: Happi, Christian T.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.